CorMedix (CRMD) Revenue Growth (1y) (2014 - 2026)
CorMedix (CRMD) Revenue Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.45% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 16.73% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.71% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 2.11% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 29.63% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 66.86% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -99.97% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 296.11% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 16.50% |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn | 156.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 156.52% |
| Dec 31, 2025 | 312.10% |
| Sep 30, 2025 | 810.22% |
| Jun 30, 2025 | 4,829.40% |
| Dec 31, 2022 | -47.33% |
| Sep 30, 2022 | -82.10% |
| Jun 30, 2022 | 159.47% |
| Mar 31, 2022 | -91.35% |
| Dec 31, 2021 | 1.23% |
| Sep 30, 2021 | -59.05% |
| Jun 30, 2021 | -50.19% |
| Mar 31, 2021 | 19.18% |
| Dec 31, 2020 | 124.85% |
| Sep 30, 2020 | 56.26% |
| Jun 30, 2020 | -53.37% |
| Mar 31, 2020 | -54.76% |
| Dec 31, 2019 | -6.58% |
| Sep 30, 2019 | -84.02% |
| Jun 30, 2019 | 367.04% |
| Mar 31, 2019 | 605.26% |